Evidence map›Paper›PMID 32266618›Full record

ArticleEnvironmental science and pollution research international2020

Antibiotic consumption in developing countries defies global commitments: an overview on Brazilian growth in consumption.

Paulo Bernardo Neves E Castro, Daniel Aparecido da Silva Rodrigues, Hubert Mathias Peter Roeser, Aníbal da Fonseca Santiago, Robson José de Cássia Franco Afonso

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Genomic characterization of a clonal emergentApplied and environmental microbiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. The occurrence of antimicrobial residues and antimicrobial resistance genes in urban drinking water and sewage in Southern Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paulo Bernardo Neves E CastroFederal University of Ouro Preto (UFOP) - ProAmb, Campus Universitário Morro do Cruzeiro, Ouro Preto, MG, 35.400-000, Brazil. paulo.castro@aluno.ufop.edu.br.
Daniel Aparecido da Silva RodriguesFederal University of Ouro Preto (UFOP) - ProAmb, Campus Universitário Morro do Cruzeiro, Ouro Preto, MG, 35.400-000, Brazil.
Hubert Mathias Peter RoeserFederal University of Ouro Preto (UFOP) - ProAmb, Campus Universitário Morro do Cruzeiro, Ouro Preto, MG, 35.400-000, Brazil.
Aníbal da Fonseca SantiagoFederal University of Ouro Preto (UFOP) - ProAmb, Campus Universitário Morro do Cruzeiro, Ouro Preto, MG, 35.400-000, Brazil.
Robson José de Cássia Franco AfonsoFederal University of Ouro Preto (UFOP) - ProAmb, Campus Universitário Morro do Cruzeiro, Ouro Preto, MG, 35.400-000, Brazil.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

Faster spread of epidemics has turned local concerns into global crises; antimicrobial resistance (AMR) is being considered a major threat to public health in the twenty-first century. Antibiotic misuse plays a great role in accelerated AMR; thus, understanding and discussing consumption patterns has been a trend topic over the past years. Developing countries, such as Brazil, have high growth rates in antibiotic consumption, potentially impacting global environmental safety. This study presents the compiled information from the Brazilian Health Regulatory Agency (ANVISA) on antibiotic dispensation across the country and maps the consumption trends between the years of 2013 and 2016. The most consumed substances were beta-lactams (amoxicillin and cephalexin) and macrolides (azithromycin). National relative growth consumption in the mentioned period was 18%. At the local level, growth of consumption ranged from 4 to 85%, with rampage growth concentrated in the North and Northeast regions. Brazilian laws, such as restriction of over-the-counter sales and mandatory report on dispensation, seem to have little effect on the national antibiotic consumption growth. This phenomenon growth is still elevated if compared with developed countries, demonstrating the need for further surveillance as well as coordinated efforts aiming at antibiotic use and AMR prevention.

Indexed as

Developing CountriesAmoxicillinAnti-Bacterial AgentsBrazilMacrolidesAmoxicillinAnti-Bacterial AgentsMacrolidesAntibioticAntimicrobial resistanceBrazilConsumptionPoliciesTrends

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.